Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,736 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cerebrovascular disease in patients with antiphospholipid antibody syndrome: a transcranial Doppler and magnetic resonance imaging study.
Ricarte IF, Dutra LA, Rodrigues DLG, Barsottini OGP, de Souza AW, Carrete H, Massaud APS, Andrade D, Mangueira CLP, Sampaio Silva G. Ricarte IF, et al. Among authors: rodrigues dlg. Rheumatol Adv Pract. 2024 May 7;8(2):rkae060. doi: 10.1093/rap/rkae060. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38800574 Free PMC article.
Molecular Evolution of RAMOSA1 (RA1) in Land Plants.
Bellino C, Herrera FE, Rodrigues D, Garay AS, Huck SV, Reinheimer R. Bellino C, et al. Among authors: rodrigues d. Biomolecules. 2024 May 3;14(5):550. doi: 10.3390/biom14050550. Biomolecules. 2024. PMID: 38785957 Free PMC article.
Correction to: Increased frequency of detection of anti‑Toxoplasma gondii antibodies in domestic cats after outbreak of human toxoplasmosis.
Fernandes FD, Tagarra LG, Roman IJ, de Oliveira Moraes DA, Rodrigues D, de Andrade CM, Bräunig P, de Oliveira-Filho EF, Cargnelutti JF, Sangioni LA, Vogel FSF. Fernandes FD, et al. Among authors: rodrigues d. Parasitol Res. 2024 May 20;123(5):213. doi: 10.1007/s00436-024-08243-9. Parasitol Res. 2024. PMID: 38767704 No abstract available.
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial.
Rescigno P, Porta N, Finneran L, Riisnaes R, Figueiredo I, Carreira S, Flohr P, Miranda S, Bertan C, Ferreira A, Crespo M, Rodrigues DN, Gurel B, Nobes J, Crabb S, Malik Z, Ralph C, McGovern U, Hoskin P, Jones RJ, Birtle A, Gale J, Sankey P, Jain S, McLaren D, Chadwick E, Espinasse A, Hall E, de Bono J. Rescigno P, et al. Among authors: rodrigues dn. Eur J Cancer. 2024 May 8;205:114103. doi: 10.1016/j.ejca.2024.114103. Online ahead of print. Eur J Cancer. 2024. PMID: 38729054 Free article.
1,736 results